Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000662:Amphetamines / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects*; D004347:Drug Interactions; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D008454:Mazindol / Q000494:pharmacology*; D008774:Methylphenidate / Q000494:pharmacology*; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D010133:p-Chloroamphetamine / Q000494:pharmacology
D000662:Amphetamines; D007211:Indoles; D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D008774:Methylphenidate; D010133:p-Chloroamphetamine; D012110:Reserpine; D008454:Mazindol